Clinical Trials Browser

Terminated × Interventional × Advanced Non-small Cell Lung Cancer × Clear all

NCT05001724 2023-04-25

KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent

Phase 2/3 Terminated

Advanced Non-small Cell Lung Cancer

NCT02200354 2019-08-14

The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab

Phase 2 Terminated

Advanced Non-small Cell Lung Cancer